Assessment of adherence to exercise intervention - percentage of performed exercise sessions.
| Group | Value | 95% CI |
|---|---|---|
| Exercise Intervention | 76 | ± 18.6 |
Last reviewed · How we verify
Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors - HEAL Sepsis Trial
NA trial testing App-based exercise program in Exercise Program in 21 participants. Completed in 29 July 2025.
| Lead sponsor | University of Florida |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 29 March 2023 |
| Primary completion | 29 July 2025 |
| Estimated completion | 29 July 2025 |
| Sites | 1 location across United States |
University of Florida
Adults 55 to 105, any sex, with Exercise Program or Standard Care Control. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Assessment of adherence to exercise intervention - percentage of performed exercise sessions.
| Group | Value | 95% CI |
|---|---|---|
| Exercise Intervention | 76 | ± 18.6 |
Recording a number of adverse events during the study period.
| Group | Value | 95% CI |
|---|---|---|
| Exercise Intervention | 11 | |
| Standard Care Control Group | 16 |
Application-guided physical function testing. The 30-second sit-to-stand test assesses lower-body strength and functional mobility by measuring the number of times a participant can rise from a seated position to a full stand and return to sitting within 30 seconds.
| Group | Value | 95% CI |
|---|---|---|
| Exercise Intervention | 1.14 | ± 2.91 |
| Standard Care Control Group | -0.88 | ± 0.99 |
Application-guided physical function testing. The 4-stage balance test assesses static balance by evaluating a participant's ability to maintain four progressively challenging standing positions for up to 10 seconds each. Successful completion of more advanced stages indicates better balance and postural control.
| Group | Value | 95% CI |
|---|---|---|
| Exercise Intervention | 5.07 | ± 4.75 |
| Standard Care Control Group | 0.01 | ± 4.38 |
Time frame: From enrollment until the end of 12-week follow-up. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.
| Reaction | System | Exercise Intervention | Standard Care Control Group |
|---|---|---|---|
| Hospitalization | Renal and urinary disorders | — | — |
| Death | General disorders | — | — |
| Reaction | System | Exercise Intervention | Standard Care Control Group |
|---|---|---|---|
| Musculoskeletal pain or associated issues | Musculoskeletal and connective tissue disorders | — | — |
| Urinary tract or kidney associated issues | Renal and urinary disorders | — | — |
| Fatigue/malaise/dizziness/nausea | General disorders | — | — |
| Respiratory issues | Respiratory, thoracic and mediastinal disorders | — | — |
| Cardiac issues | Cardiac disorders | — | — |
| Eye disorders | Eye disorders | — | — |
| Infections (non-UTI/respiratory) | Infections and infestations | — | — |
| Falls or injuries | Injury, poisoning and procedural complications | — | — |
Most-reported serious reactions: Hospitalization, Death.
Data from ClinicalTrials.gov NCT05568511 adverse events section.
Older sepsis survivors have poor physical function and need post-sepsis physical rehabilitation. Often times, sepsis survivors live far from research facilities and do not have access to rehabilitation services. Remotely delivered exercise intervention could be the key to improve physical function in this population. Therefore, the study proposes to recruit older sepsis survivors at discharge from the hospital to home and assign them to either exercise training or standard care.
2 peer-reviewed publications reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05568511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing